Prognostic impact of HER2 overexpression/amplification in women with pT1a NO MO breast cancer with known screening status: Results from a multicenter population-based cancer registry study

被引：0
|
作者：
Musolino, A.
Michiara, M.
Boggiani, D.
Sikokis, A.
Rimanti, A.
Pellegrino, B.
Silini, E. M.
Campanini, N.
Barbieri, E.
Sgargi, P.
Falcini, F.
Pinto, C.
机构：
[1] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[2] Univ Hosp Parma, Canc Registry Parma Prov, Parma, Italy
[3] Univ Hosp Parma, Sect Anat & Pathol, Parma, Italy
[4] St Orsola Marcello Malpighi Hosp, SSD Oncol Med Addarii, Bologna, Italy
[5] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori, Romagna Tumor Registry, Meldola, Italy
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P1-07-23
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-07-23
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prognostic role of HER2 expression in patients with estrogen receptor positive/HER2-negative breast cancer. Results from a populationbased cancer registry study
    Tommasi, C.
    Coriano, M.
    Serra, O.
    Pellegrino, B.
    Zanoni, D.
    Faccini, F.
    Michiara, M.
    Sgargi, P.
    Giuliano, C.
    Ferretti, S.
    Grossi, V.
    Ravaioli, A.
    Zamagni, F.
    Falcini, F.
    Musolino, A.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 37 - 37
  • [22] Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program
    Morey, Adrienne L.
    Brown, Belinda
    Farshid, Gelareh
    Fox, Stephen B.
    Francis, Glenn D.
    McCue, Glenda
    von Neumann-Cosel, Vita
    Bilous, Michael
    PATHOLOGY, 2016, 48 (06) : 535 - 542
  • [23] HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab
    O'Malley, Frances P.
    Thomson, Tom
    Julian, Jim
    Have, Cherry
    Crosby, Roxanne
    Gelmon, Karen
    Andrulis, Irene
    Whelan, Tim
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (01) : 61 - 65
  • [24] Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute Study
    Mahyari, Hanifeh Mirtavoos
    Khosravi, Adnan
    Mahyari, Zeinab Mirtavoos
    Monfared, Zahra Esfahani
    Khosravi, Negin
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (11)
  • [25] HER2 Overexpression Is a Major Risk Factor for Recurrence in pT1a-b, N0 Breast Cancer: A French Regional Population-Based Study of 671 Patients
    Bibeau, F.
    Boissiere-Michot, F.
    Denouel, A.
    Szablewski, V.
    Perrocchia, H.
    Pignodel, C.
    de Vullerin, A. Gudin
    Leaha, C.
    Chateau, M-C
    Barneon, G.
    Vic, P.
    Garnier, A.
    Granier, M.
    Roger, P.
    MODERN PATHOLOGY, 2012, 25 : 26A - 26A
  • [26] Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status
    Ha, Seon-Ah
    Lee, Youn Soo
    Shin, Seung Min
    Kim, Hyun Kee
    Kim, Sanghee
    Namkoong, Hong
    Kim, Hae Joo
    Jung, Sang Min
    Lee, Yu Sun
    Chung, Yeun Jun
    Jung, Sang Seol
    Kim, Jin Woo
    BMC CANCER, 2009, 9
  • [27] Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status
    Seon-Ah Ha
    Youn Soo Lee
    Seung Min Shin
    Hyun Kee Kim
    Sanghee Kim
    Hong Namkoong
    Hae Joo Kim
    Sang Min Jung
    Yu Sun Lee
    Yeun Jun Chung
    Sang Seol Jung
    Jin Woo Kim
    BMC Cancer, 9
  • [28] HER2 overexpression and amplification in advanced ovarian cancer (OC):: Preliminary results from a large GINECO study.
    Camilleri-Broët, S
    Guastalla, JP
    Couturier, J
    Curé, H
    Penault-Llorca, F
    Allouache, D
    Vincent-Salomon, A
    Paraïso, D
    Pujade-Lauraine, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 469S - 469S
  • [29] Multifactorial CNS relapse susceptibility in HER-2-positive breast cancer patients: first results from a population-based registry study
    Musolino, A.
    Ciccolallo, L.
    Panebianco, M.
    Fontana, E.
    Zanoni, D.
    De Lisi, V.
    Ardizzoni, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 316 - 316
  • [30] MULTIFACTORIAL CNS RELAPSE SUSCEPTIBILITY IN HER-2-POSITIVE BREAST CANCER PATIENTS: FIRST RESULTS FROM A POPULATION-BASED REGISTRY STUDY
    Musolino, Antonino
    Ciccolallo, Laura
    Panebianco, Michele
    Fontana, Elisa
    Zanoni, Daniele
    De Lisi, Vincenzo
    Ardizzoni, Andrea
    ANNALS OF ONCOLOGY, 2009, 20
12345